There have been 50 recent insider transactions recorded for Ocular Therapeutix, Inc. (OCUL), including 19 buys and 24 sells. Total insider buying was valued at $44.07M and total insider selling at $3.1M.
Notable insiders with recent activity include Heier Jeffrey S., Dugel Pravin, Kaiser Peter. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — OCUL
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-02-23 |
Heier Jeffrey S. |
Chief Scientific Officer |
Informative Sell |
3,057 |
$8.28 |
$25.31K |
323,368 |
| 2026-02-23 |
Dugel Pravin |
See Remarks |
Informative Sell |
20,056 |
$8.28 |
$166.06K |
3,013,022 |
| 2026-02-23 |
Kaiser Peter |
Chief Development Officer |
Informative Sell |
2,810 |
$8.28 |
$23.27K |
269,108 |
| 2026-02-23 |
Nayak Sanjay |
Chief Strategy Officer |
Informative Sell |
1,759 |
$8.28 |
$14.56K |
330,653 |
| 2026-02-20 |
Lindstrom Richard L Md |
Director |
Informative Buy |
60,229 |
$7.66 |
$461.35K |
246,933 |
| 2026-02-20 |
Waheed Nadia |
Chief Medical Officer |
Informative Sell |
3,510 |
$7.74 |
$27.17K |
314,907 |
| 2026-02-12 |
Dugel Pravin |
See Remarks |
Informative Sell |
124,882 |
$9.04 |
$1.13M |
3,033,078 |
| 2026-02-12 |
Notman Donald |
Chief Operating Officer |
Informative Sell |
11,446 |
$9.04 |
$103.47K |
366,356 |
| 2026-02-12 |
Nayak Sanjay |
Chief Strategy Officer |
Informative Sell |
10,348 |
$9.04 |
$93.55K |
332,412 |
| 2026-02-12 |
Waheed Nadia |
Chief Medical Officer |
Informative Sell |
7,863 |
$9.04 |
$71.08K |
318,417 |
| 2026-02-04 |
Notman Donald |
Chief Operating Officer |
Informative Sell |
6,035 |
$8.54 |
$51.54K |
377,802 |
| 2026-02-02 |
Notman Donald |
Chief Operating Officer |
Informative Sell |
5,455 |
$9.14 |
$49.86K |
383,837 |
| 2026-01-21 |
Robinson David Wayne |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-01-21 |
Robinson David Wayne |
Global Cco |
RSU Award |
136,000 |
- |
- |
136,000 |
| 2026-01-20 |
Robins Jason Shand |
Interim CFO |
Unknown |
110,600 |
$8.12 |
$898.07K |
- |
| 2026-01-20 |
Robins Jason Shand |
Interim CFO |
RSU Award |
33,000 |
$11.45 |
$377.85K |
33,000 |
| 2026-01-02 |
Heier Jeffrey S. |
Chief Scientific Officer |
RSU Award |
240,932 |
$11.82 |
$2.85M |
240,932 |
| 2026-01-02 |
Notman Donald |
See Remarks |
RSU Award |
240,932 |
$11.82 |
$2.85M |
240,932 |
| 2026-01-02 |
Kaiser Peter |
Chief Development Officer |
RSU Award |
240,932 |
$11.82 |
$2.85M |
240,932 |
| 2026-01-02 |
Nayak Sanjay |
Chief Strategy Officer |
RSU Award |
197,650 |
$11.82 |
$2.34M |
197,650 |
| 2026-01-02 |
Waheed Nadia |
Chief Medical Officer |
RSU Award |
240,932 |
$11.82 |
$2.85M |
240,932 |
| 2026-01-02 |
Anderman Todd |
Chief Legal Officer |
RSU Award |
64,900 |
- |
- |
152,468 |
| 2026-01-02 |
Saroj Namrata |
Chief Business Officer |
RSU Award |
240,932 |
$11.82 |
$2.85M |
240,932 |
| 2026-01-02 |
Meyers Steve Lawrence |
Chief Commercial Officer |
RSU Award |
197,650 |
$11.82 |
$2.34M |
197,650 |
| 2025-11-26 |
Dugel Pravin |
See Remarks |
Gift (Given) |
49,754 |
- |
- |
- |
| 2025-11-24 |
Heier Jeffrey S. |
Chief Scientific Officer |
Informative Sell |
3,469 |
$12.04 |
$41.77K |
245,940 |
| 2025-11-24 |
Dugel Pravin |
See Remarks |
Informative Sell |
19,530 |
$12.04 |
$235.14K |
3,157,960 |
| 2025-11-24 |
Kaiser Peter |
Chief Development Officer |
Informative Sell |
3,007 |
$12.02 |
$36.14K |
191,433 |
| 2025-11-24 |
Nayak Sanjay |
Chief Strategy Officer |
Informative Sell |
1,878 |
$12.04 |
$22.61K |
277,860 |
| 2025-11-05 |
Saroj Namrata |
Chief Business Officer |
Informative Sell |
25,865 |
$10.74 |
$277.79K |
174,135 |
| 2025-10-08 |
Anderman Todd |
Chief Legal Officer |
Informative Sell |
11,132 |
$12.34 |
$137.37K |
87,568 |
| 2025-10-02 |
Heier Jeffrey S. |
Chief Scientific Officer |
Informative Sell |
10,502 |
$11.04 |
$115.94K |
249,409 |
| 2025-10-02 |
Kaiser Peter |
Chief Development Officer |
Informative Sell |
9,653 |
$11.03 |
$106.47K |
194,440 |
| 2025-09-09 |
Dugel Pravin |
See Remarks |
Gift (Received) |
49,754 |
- |
- |
49,754 |
| 2025-09-02 |
Notman Donald |
See Remarks |
Informative Sell |
1,066 |
$12.43 |
$13.25K |
308,807 |
| 2025-08-25 |
Heier Jeffrey S. |
Chief Scientific Officer |
Informative Sell |
3,063 |
$12.04 |
$36.88K |
259,911 |
| 2025-08-25 |
Dugel Pravin |
See Remarks |
Informative Sell |
21,494 |
$12.04 |
$258.79K |
3,227,244 |
| 2025-08-25 |
Kaiser Peter |
Chief Development Officer |
Informative Sell |
3,011 |
$12.04 |
$36.25K |
204,093 |
| 2025-08-25 |
Nayak Sanjay |
Chief Strategy Officer |
Informative Sell |
1,885 |
$12.04 |
$22.7K |
279,738 |
| 2025-08-12 |
Waheed Nadia |
Chief Medical Officer |
RSU Award |
122,923 |
$12.48 |
$1.53M |
122,923 |
| 2025-08-11 |
Dugel Pravin |
See Remarks |
Gift (Received) |
250,361 |
- |
- |
250,361 |
| 2025-06-12 |
Dugel Pravin |
See Remarks |
Gift (Given) |
50,029 |
- |
- |
3,248,738 |
| 2025-06-11 |
Raines Merilee |
Director |
RSU Award |
44,000 |
$8.82 |
$388.08K |
44,000 |
| 2025-06-11 |
Lindstrom Richard L Md |
Director |
RSU Award |
44,000 |
$8.82 |
$388.08K |
44,000 |
| 2025-06-11 |
Graves Adrienne L |
Director |
RSU Award |
44,000 |
$8.82 |
$388.08K |
44,000 |
| 2025-06-11 |
Warden Charles M |
Director |
RSU Award |
44,000 |
$8.82 |
$388.08K |
44,000 |
| 2025-06-11 |
Dugel Pravin |
See Remarks |
RSU Award |
2,750,000 |
$7.44 |
$20.46M |
2,750,000 |
| 2025-06-11 |
Williams Leslie J. |
Director |
RSU Award |
44,000 |
$8.82 |
$388.08K |
44,000 |
| 2025-06-11 |
Hong Seung Suh |
Director |
RSU Award |
44,000 |
$8.82 |
$388.08K |
44,000 |
| 2025-06-11 |
Saroj Namrata |
Chief Business Officer |
Unknown |
316,000 |
$10.27 |
$3.25M |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
